Indications and safety of newer IBD treatments in the older patient
Benjamin Clément, Kara De Felice, Anita Afzali
Topics & Concepts
MedicineUstekinumabVedolizumabTofacitinibAdverse effectInflammatory bowel diseaseIntensive care medicineMalignancyInternal medicineDermatologyDiseaseAdalimumabRheumatoid arthritisInflammatory Bowel DiseaseImmunodeficiency and Autoimmune DisordersChronic Lymphocytic Leukemia Research